Colchicine may decrease cardiovascular events in patients with coronary artery disease

This oral anti-inflammatory agent may offer a low-cost option for prevention of cardiovascular events in this patient population.Leslie Griffin, MD; Julia Groce, MD; Sara Conway, MD (University of Tennessee, College of Medicine, Chattanooga). Deputy Editor: Corey Lyon, DO (University of Colorado, Denver)Includes bibliographical reference